Compounds, methods and pharmaceutical compositions for inhibiting PARP
View Patent ↗The present invention provides compounds which inhibit poly(ADP-ribose) polymerase (“PARP”), compositions containing these compounds and methods for using these PARP inhibitors to treat, prevent and/or ameliorate the effects of the conditions described herein.
1. A compound selected from the group consisting of:
2. A method of treating diseases or conditions selected from the group consisting of neural tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorder, arthritis, gout, chronic pain, acute pain, neuropathic pain, renal failure, retinal ischemia and septic shock, comprising administering to said animal an effective amount of a compound of claim 1 .
3. The method of claim 2 , wherein said cerebral ischemia or reperfusion injury is cerebral injury after cardiac arrest and cardio-pulmonary resuscitation.
4. The method of claim 2 , wherein the septic shock is endotoxic shock.
5. The method of claim 2 , wherein the bowel disorder is colitis.
6. A pharmaceutical composition comprising of:
a therapeutically effective amount of a compound of claim 1 ; and
a pharmaceutically acceptable carrier.